Company profile
Aspyra Inc.
OTC: APYI · Healthcare · Medical - Healthcare Information Services
#651 of 1,418 Healthcare companies by revenue29th-percentile growth
EA Score
——FH —DQ —GM —SS 51
v0.1 · 5/100 weight · pillars only
↑ operating margin, listing tenure · ↓ market scale, Piotroski F
Methodology →Revenue TTM
$7.7M
Rev growth YoY (TTM)
-15.6%
Net income (FY)
-$5.2M
Employees
69
as of 2026-08-31
Market cap
$34
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$8.5M$8.5M2008
Net income-$5.2M-$5.2M2008
Operating income$4.7M$4.7M2008
Total assets$15.2M$15.2M2008
Liabilities$8.4M$8.4M2008
Equity$6.8M$6.8M2008
Revenue trend
FY2001 – FY2008 · USD
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Aspyra Inc.’s revenue?
Aspyra Inc. booked $8.5M in FY2008 revenue, contracting 17% year over year — slower than 71% of Healthcare companies we track, at a -60.9% net margin.
Peers · Healthcare
Milestone Scientific Inc.41DHerbal Dispatch Inc.52DMJardin Group, Inc.——Nuwellis, Inc.43DSolid Biosciences Inc.41DNextleaf Solutions Ltd.57CNeighbors
Duval →Key facts
CEOGary W. Bennett
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersJacksonville, FL
ExchangeOTC: APYI
Employees69
IPO date1983-09-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.